VNDA
VNDA
NASDAQ · Biotechnology

Vanda Pharmaceuticals Inc

$3.82
+0.23 (+6.41%)
As of Nov 7, 10:20 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +304.5% upside
Low Target $11.33
Average Target $15.45
High Target $18.37
Current Price $3.82
Current
$3.82
Target
$15.45
$11.33 $15.45 avg $18.37
Scenario Analysis
Bear Case
$11.33
196.6%
Low target
Base Case
$15.45
+304.5%
Avg target
Bull Case
$18.37
+380.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$9.94
-61.6% from high
52-Week Low
$3.57
+7.2% from low
Target vs 52W High
$15.45
+55.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -40.7%